Skip to main content
Log in

Use of 111In-pentetreotide scintigraphy for diagnosis and management of resistant macroprolactinoma

  • Endocrine Imaging
  • Published:
Endocrine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. R.V. Lloyd, R.Y. Osamura, G. Kloppel, J. Rosai, WHO Classification of Tumors of Endocrine Organs (WHO International Agency, Lion France, 2017)

  2. A. Fusco, F. Lugli, E. Sacco, L. Tilaro, A. Bianchi, F. Angelini, A. Tofani, A. Barini, L. Lauriola, G. Maira, A. Pontecorvi, L. De Marinis, Efficacy of the combined cabergoline and octreotide treatment in a case of a dopamine-agonist resistant macroprolactinoma. Pituitary 14, 351–357 (2011). https://doi.org/10.1007/s11102-008-0162-y

    Article  PubMed  Google Scholar 

  3. S.W.J. Lamberts, L.J. Hofland, Future treatment strategies of aggressive pituitary tumors. Pituitary 12, 261–264 (2009). https://doi.org/10.1007/s11102-008-0154-y

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This case is a courtesy of Prof. Laura De Marinis, Chair of Pituitary Unit of the Department of Endocrinology. All the authors wish to thank Prof. Laura De Marinis, who manages and follows-up the patient and offers clinical data for the paper. Moreover the authors wish to thank Dr. Tommaso Tartaglione and Prof. Cesare Colosimo (Institute of Radiology), Dr. Germano Perotti and Prof. Alessandro Giordano (Department of Nuclear Medicine) for the diagnostic and images support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Chiloiro.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Del Gatto, V., Bima, C., Chiloiro, S. et al. Use of 111In-pentetreotide scintigraphy for diagnosis and management of resistant macroprolactinoma. Endocrine 60, 532–534 (2018). https://doi.org/10.1007/s12020-017-1486-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-017-1486-z

Keywords

Navigation